Europe Atopic Dermatitis Drugs Market

Europe Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Country and Growth Forecast, 2022 - 2028

Report Id: KBV-12218 Publication Date: November-2022 Number of Pages: 82
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
TABLE 1 Europe Atopic Dermatitis Drugs Market, 2018 - 2021, USD Million
TABLE 2 Europe Atopic Dermatitis Drugs Market, 2022 - 2028, USD Million
TABLE 3 Acquisition and Mergers– Atopic Dermatitis Drugs Market
TABLE 4 Approvals and trials – Atopic Dermatitis Drugs Market
TABLE 5 Europe Atopic Dermatitis Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 6 Europe Atopic Dermatitis Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 7 Europe Injectable Market by Country, 2018 - 2021, USD Million
TABLE 8 Europe Injectable Market by Country, 2022 - 2028, USD Million
TABLE 9 Europe Oral Market by Country, 2018 - 2021, USD Million
TABLE 10 Europe Oral Market by Country, 2022 - 2028, USD Million
TABLE 11 Europe Topical Market by Country, 2018 - 2021, USD Million
TABLE 12 Europe Topical Market by Country, 2022 - 2028, USD Million
TABLE 13 Europe Atopic Dermatitis Drugs Market by Class, 2018 - 2021, USD Million
TABLE 14 Europe Atopic Dermatitis Drugs Market by Class, 2022 - 2028, USD Million
TABLE 15 Europe Biologics Market by Country, 2018 - 2021, USD Million
TABLE 16 Europe Biologics Market by Country, 2022 - 2028, USD Million
TABLE 17 Europe Calcineurin Inhibitors Market by Country, 2018 - 2021, USD Million
TABLE 18 Europe Calcineurin Inhibitors Market by Country, 2022 - 2028, USD Million
TABLE 19 Europe Corticosteroids Market by Country, 2018 - 2021, USD Million
TABLE 20 Europe Corticosteroids Market by Country, 2022 - 2028, USD Million
TABLE 21 Europe PDE4 Inhibitors Market by Country, 2018 - 2021, USD Million
TABLE 22 Europe PDE4 Inhibitors Market by Country, 2022 - 2028, USD Million
TABLE 23 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 24 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 25 Europe Atopic Dermatitis Drugs Market by Country, 2018 - 2021, USD Million
TABLE 26 Europe Atopic Dermatitis Drugs Market by Country, 2022 - 2028, USD Million
TABLE 27 Germany Atopic Dermatitis Drugs Market, 2018 - 2021, USD Million
TABLE 28 Germany Atopic Dermatitis Drugs Market, 2022 - 2028, USD Million
TABLE 29 Germany Atopic Dermatitis Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 30 Germany Atopic Dermatitis Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 31 Germany Atopic Dermatitis Drugs Market by Class, 2018 - 2021, USD Million
TABLE 32 Germany Atopic Dermatitis Drugs Market by Class, 2022 - 2028, USD Million
TABLE 33 UK Atopic Dermatitis Drugs Market, 2018 - 2021, USD Million
TABLE 34 UK Atopic Dermatitis Drugs Market, 2022 - 2028, USD Million
TABLE 35 UK Atopic Dermatitis Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 36 UK Atopic Dermatitis Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 37 UK Atopic Dermatitis Drugs Market by Class, 2018 - 2021, USD Million
TABLE 38 UK Atopic Dermatitis Drugs Market by Class, 2022 - 2028, USD Million
TABLE 39 France Atopic Dermatitis Drugs Market, 2018 - 2021, USD Million
TABLE 40 France Atopic Dermatitis Drugs Market, 2022 - 2028, USD Million
TABLE 41 France Atopic Dermatitis Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 42 France Atopic Dermatitis Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 43 France Atopic Dermatitis Drugs Market by Class, 2018 - 2021, USD Million
TABLE 44 France Atopic Dermatitis Drugs Market by Class, 2022 - 2028, USD Million
TABLE 45 Russia Atopic Dermatitis Drugs Market, 2018 - 2021, USD Million
TABLE 46 Russia Atopic Dermatitis Drugs Market, 2022 - 2028, USD Million
TABLE 47 Russia Atopic Dermatitis Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 48 Russia Atopic Dermatitis Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 49 Russia Atopic Dermatitis Drugs Market by Class, 2018 - 2021, USD Million
TABLE 50 Russia Atopic Dermatitis Drugs Market by Class, 2022 - 2028, USD Million
TABLE 51 Spain Atopic Dermatitis Drugs Market, 2018 - 2021, USD Million
TABLE 52 Spain Atopic Dermatitis Drugs Market, 2022 - 2028, USD Million
TABLE 53 Spain Atopic Dermatitis Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 54 Spain Atopic Dermatitis Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 55 Spain Atopic Dermatitis Drugs Market by Class, 2018 - 2021, USD Million
TABLE 56 Spain Atopic Dermatitis Drugs Market by Class, 2022 - 2028, USD Million
TABLE 57 Italy Atopic Dermatitis Drugs Market, 2018 - 2021, USD Million
TABLE 58 Italy Atopic Dermatitis Drugs Market, 2022 - 2028, USD Million
TABLE 59 Italy Atopic Dermatitis Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 60 Italy Atopic Dermatitis Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 61 Italy Atopic Dermatitis Drugs Market by Class, 2018 - 2021, USD Million
TABLE 62 Italy Atopic Dermatitis Drugs Market by Class, 2022 - 2028, USD Million
TABLE 63 Rest of Europe Atopic Dermatitis Drugs Market, 2018 - 2021, USD Million
TABLE 64 Rest of Europe Atopic Dermatitis Drugs Market, 2022 - 2028, USD Million
TABLE 65 Rest of Europe Atopic Dermatitis Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 66 Rest of Europe Atopic Dermatitis Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 67 Rest of Europe Atopic Dermatitis Drugs Market by Class, 2018 - 2021, USD Million
TABLE 68 Rest of Europe Atopic Dermatitis Drugs Market by Class, 2022 - 2028, USD Million
TABLE 69 Key Information – Pfizer, Inc.
TABLE 70 Key Information – Novartis AG
TABLE 71 Key Information – Sanofi S.A.
TABLE 72 key information – LEO Pharma A/S
TABLE 73 Key Information – INCYTE CORPORATION
TABLE 74 Key information – AbbVie, Inc.
TABLE 75 Key Information – Regeneron Pharmaceuticals, Inc.
TABLE 76 Key Information – Eli Lilly And Company
TABLE 77 key information – Otsuka Pharmaceutical Co., Ltd.
TABLE 78 Key Information – Galderma S.A.

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2018, SeP – 2022, Oct) Leading Players
FIG 5 Recent strategies and developments: Pfizer, Inc.
FIG 6 Recent strategies and developments: sanofi s.a.
FIG 7 Recent strategies and developments: leo pharma a/s
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo